Cystinuria is a genetic condition that causes kidney stones made from the amino acid cystine. People with cystinuria often have repeated stones that can cause flank pain, blood in the urine, and urinary tract infections. It is lifelong and usually shows up in childhood, the teen years, or early adulthood, and not everyone will have the same experience. Treatment focuses on prevention with high fluid intake, urine-alkalizing medicines, and sometimes drugs that bind cystine, and procedures may be needed to remove larger stones. Cystinuria rarely affects life expectancy, but early symptoms of cystinuria and regular follow-up help reduce complications.
Overview
CystinuriaSymptoms
Cystinuria mainly causes recurrent cystine kidney stones. People may have sudden severe side or back pain, blood in the urine, nausea, or urinary urgency; infections can occur. Early symptoms of cystinuria often appear in childhood or the teen years.
Outlook and prognosis
Most people with cystinuria live full lives, though kidney stones often recur and may start in childhood or young adulthood. With plenty of fluids, urine-alkalizing medicines, and tailored stone prevention, episodes usually become less frequent. Regular follow-up helps protect kidney function long term.
Causes and risk factors
Cystinuria is caused by inherited changes in kidney transport genes, usually autosomal recessive. Risk rises with family history or carrier parents. Low fluid intake, high salt or animal protein, and acidic urine can increase stone risk.
Genetic influences
Genetics are central in cystinuria; it’s an inherited condition caused by changes in SLC3A1 or SLC7A9. These variants affect kidney transport, raising cystine levels and stone risk. Family history matters, and relatives may consider genetic counseling or testing.
Diagnosis
Doctors suspect cystinuria with recurrent kidney stones, often starting young. Genetic diagnosis of Cystinuria relies on urine tests showing excess cystine or hexagonal crystals, stone analysis, and imaging; genetic tests can confirm and support family screening.
Treatment and drugs
Cystinuria care focuses on preventing stones and easing symptoms. Many people use high fluid intake, urine-alkalinizing agents (like potassium citrate), and medicines that bind cystine; pain control and targeted antibiotics are used when needed. Procedures such as ureteroscopy or lithotripsy remove stubborn stones.
Symptoms
Recurring kidney stones are the main issue for many living with cystinuria, often starting in the teens or young adulthood. Features vary from person to person and can change over time. Early features of cystinuria may be cloudy or gritty urine, mild back twinges, or blood that only shows up on a urine test. When stones move, pain can be intense and may return in cycles across a lifetime.
Sudden, severe pain on one side of the back or lower belly, often in waves. It can spread toward the groin as the stone moves. In cystinuria, these episodes can happen repeatedly.
Urine may look pink, red, or tea-colored. Sometimes blood only shows up on a urine test after a stone irritates the urinary tract.
You may see cloudy urine or tiny, sand-like crystals. Sometimes you’ll pass small crystals before larger stones form.
A sharp, burning feeling when peeing can happen as a stone passes. You may feel an urgent need to go, with only a small amount coming out.
How people usually first notice Cystinuria?
Many people first notice cystinuria when a sudden, sharp pain in the side or lower back sends them to urgent care or the emergency department, and imaging shows a kidney stone made of cystine. For some, the first signs of cystinuria show up earlier as recurrent urinary tract symptoms, blood in the urine, or stones in childhood or the teenage years, especially if there’s a family history of kidney stones. Doctors often confirm how cystinuria is first noticed by testing urine for high cystine levels and identifying characteristic stones on imaging.
Types of Cystinuria
Cystinuria has a few well-defined genetic variants that influence how early kidney stones appear and how often they come back. These clinical variants relate to changes in two partner genes that help move certain amino acids in the kidney. Not everyone will have the same pattern of stone events or urine findings, even within the same family. When people search for types of Cystinuria, they’re usually referring to these recognized genetic variants rather than different complications.
Type A (SLC3A1)
Changes in the SLC3A1 gene affect a transporter subunit and reduce cystine reabsorption in the kidney. People often develop recurrent cystine stones from childhood or young adulthood. Severity can vary widely between families.
Type B (SLC7A9)
Variants in the SLC7A9 gene affect the partner subunit of the same transporter. Stone risk can range from mild to frequent, even among relatives with the same change. Some carriers may have elevated cystine in urine without many stones.
Type AB (digenic)
Pathogenic changes in both SLC3A1 and SLC7A9 occur together. Features can overlap with type A or B, and stone frequency may be similar to other types. Testing helps confirm this variant.
Type A with I173T
A specific SLC3A1 change (often noted as I173T) is seen in some populations. It leads to the same transport problem but can be linked with earlier onset in certain families. Doctors may mention it when discussing variants of Cystinuria.
What genetics can tell you about symptoms
Certain SLC3A1 gene changes often cause earlier kidney stones made of cystine, frequent flank pain, and urine that may look cloudy with a sulfur-like smell. Variants in SLC7A9 can bring similar stones but sometimes later, with milder, intermittent symptoms between episodes.
Causes and risk factors
Cystinuria is caused by inherited changes in the SLC3A1 or SLC7A9 genes, usually from both parents. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Common risk factors for cystinuria that you cannot change include family history and being male. Dehydration, low fluid intake, and high salt (sodium) intake can raise the chance of stones in cystinuria. Hot weather, heavy sweating, and more acidic urine can also increase risk.
Environmental and biological risk factors
Cystinuria is present from birth, and current research points to very few outside influences on whether it occurs. Doctors often group risks into internal (biological) and external (environmental). For this condition, no specific environmental or additional biological factors have been confirmed to raise the chance of having it. If early symptoms of cystinuria appear later, they reflect a condition that already exists rather than a change in risk.
No specific exposures such as radiation, heavy metals, solvents, or air pollution have been shown to raise the chance of cystinuria. Studies to date have not found consistent links between toxins, infections, or water quality and risk.
Having an older mother or father at conception has not been shown to increase the likelihood of cystinuria. Current data do not support an age-related effect.
Common pregnancy health issues or medications have not been linked to a higher risk of cystinuria. No specific prenatal exposure has been confirmed to increase likelihood.
Prematurity, low birth weight, or delivery complications have not been associated with a higher chance of cystinuria. Available evidence does not support birth events as risk modifiers.
Genetic risk factors
In most people, Cystinuria happens because of inherited changes in two genes that help the kidneys reclaim certain amino acids. Some risk factors are inherited through our genes. The condition generally follows an autosomal recessive pattern, so symptoms arise when gene changes are present on both copies; people with one copy changed are typically carriers with little or no symptoms. Genetic testing can identify the exact gene involved and clarify risks for relatives.
SLC3A1 variants: Changes in the SLC3A1 gene are a common cause of Cystinuria. They weaken a kidney transporter so cystine stays in the urine and can form stones. Many with two SLC3A1 changes notice stones in childhood or early adulthood.
SLC7A9 variants: Changes in the SLC7A9 gene also cause Cystinuria. They affect the partner transporter and raise the chance of cystine stones. Age at first stone and severity can vary widely.
Both genes affected: Having one disease-causing change in SLC3A1 and one in SLC7A9 can also lead to Cystinuria. Disruption on both sides of the transporter pair leads to high cystine in urine. Genetic testing can confirm this pattern.
Autosomal recessive pattern: Cystinuria usually appears when a child inherits one nonworking copy of the gene from each parent. Each full sibling then has a 25% (1 in 4) chance of having Cystinuria. Parents with one change are typically carriers.
Carrier parents: When both parents carry a Cystinuria-related gene change, the chance of an affected child is increased. Carriers are healthy in most cases but can pass the change to their children. Carrier testing in relatives can clarify risks.
Single-variant carriers: People with just one SLC3A1 or SLC7A9 change are usually free of Cystinuria. Some have mildly higher cystine in urine and a small chance of stones. Most never develop symptoms.
Family history: Having a sibling or parent with Cystinuria raises the likelihood of sharing the same gene changes. This is especially true when stones start young or recur often. Knowing early symptoms of Cystinuria can prompt earlier urine checks and genetic testing.
Parental relatedness: Parents who are related by blood are more likely to carry the same rare gene change. This increases the chance their children inherit two changes and develop Cystinuria. Genetic counseling can help families understand these chances.
Variable severity: People with the same Cystinuria gene changes can have very different stone patterns. Some have frequent stones, while others have long quiet periods. Other inherited modifiers likely contribute, though they are not fully defined.
Ancestry-linked variants: Certain SLC3A1 or SLC7A9 changes are more common in specific ancestries or regions. This can cluster Cystinuria in some families or communities. Knowledge of ancestry can help choose the right genetic test.
Lifestyle risk factors
Cystinuria is inherited; lifestyle habits do not cause it, but they strongly influence stone formation, symptoms, and complications. Understanding how lifestyle affects Cystinuria can help you reduce episodes and protect kidney function. Here are the main lifestyle risk factors for Cystinuria and practical ways to modify them.
Not drinking enough concentrates urine, pushing cystine above its solubility and promoting stones. Spreading fluids across the day and before bed helps keep cystine diluted.
Excess salt increases urinary cystine excretion via kidney transport, raising stone risk. Cutting back on added salt and salty foods can lower the cystine load.
Large portions of meat, fish, and poultry increase acid load and cystine production, reducing its solubility. Shifting toward plant-forward proteins can lessen precipitation.
Diets low in fruits and vegetables keep urine acidic, which makes cystine less soluble. Choosing alkalinizing foods and citrate-containing drinks can help raise urine pH toward your target.
Risk prevention
Living with cystinuria means focusing on steps that lower the chance of new kidney stones and protect kidney function over time. Prevention is about lowering risk, not eliminating it completely. Daily habits like generous hydration, less salt, and keeping urine less acidic can make stones less likely. Your care team may add medicines and monitoring when lifestyle steps aren’t enough.
Drink enough to produce 3–4 liters (100–135 oz) of urine daily. Spread fluids through the day and include a glass before bed to dilute nighttime urine.
Under your doctor’s guidance, use alkali like potassium citrate to keep urine pH around 7.0–7.5. Checking urine pH at home helps you fine-tune dosing.
Limit salt to under 2,000 mg sodium per day (about 5 g of table salt). Less sodium lowers cystine in urine and reduces stone risk.
Aim for moderate portions of animal protein and include more plant-based proteins. Excess animal protein can make urine more acidic and increase cystine.
Transmission
Cystinuria is a genetic condition and is not contagious—you can’t catch it or pass it to others through touch, sneezing, food, or sex.
How Cystinuria is inherited is autosomal recessive: most often a child receives one nonworking copy of the gene from each parent, who usually have no symptoms. When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of a child with cystinuria, a 1 in 2 (50%) chance of a carrier, and a 1 in 4 (25%) chance of a child who inherits neither change. New, spontaneous gene changes can happen but are rare; in most families, cystinuria is inherited from carrier parents.
When to test your genes
Consider genetic testing if you’ve had repeated kidney stones, stones starting in childhood, or stones that are mostly cystine. Test sooner if a close relative has cystinuria or early, recurrent stones. Results can guide high-fluid, urine-alkalinizing, and medication plans, and inform family planning and testing for relatives.
Diagnosis
Recurring kidney stones at a young age can interrupt work, school, or sleep, and many living with cystinuria describe sudden, severe flank pain that leads to urgent visits. Doctors usually begin by connecting these patterns—early-onset stones, frequent recurrences, and family history—to targeted urine and imaging tests. Because cystinuria is present from birth and affects how certain amino acids are handled, testing focuses on what shows up in urine and in the stones themselves. Results from these steps guide whether genetic tests are helpful for confirmation and family planning.
Clinicians ask about age at first stone, pain episodes, stone passage, and prior procedures. A detailed family and health history can help reveal patterns that point to cystinuria.
A fresh urine sample is examined for classic flat, hexagonal crystals. Finding these crystals strongly suggests cystinuria, especially in people with recurrent stones.
A quick urine screen (cyanide-nitroprusside) checks for excess cystine. A positive result supports cystinuria but is confirmed with more specific tests.
Lab measurement of cystine over 24 hours quantifies how much is being lost in urine. High cystine levels help confirm the diagnosis and guide treatment goals.
Stages of Cystinuria
Cystinuria does not have defined progression stages. Instead, it tends to cause repeated kidney stones that come and go, so severity is judged by how often stones form and whether complications happen, not by a staged scale. Doctors usually start with a conversation about symptoms such as sudden side or back pain, blood in the urine, or passing small stones—these early symptoms of cystinuria are followed by urine and imaging tests. Urinalysis can show characteristic crystals, 24-hour urine testing looks for high cystine, imaging such as ultrasound or CT checks for stones, and genetic testing may be offered to confirm the cause and guide long-term monitoring.
Outlook and prognosis
Daily routines often adapt as people with cystinuria learn what keeps kidney stones at bay—more water during the day, a bottle by the bed, and quick action when early symptoms of cystinuria like side or back pain, burning with urination, or cloudy urine show up. Doctors call this the prognosis—a medical word for likely outcomes. Most people with cystinuria have a normal life expectancy, but repeated stones can lead to infections, procedures, and, if unmanaged, a higher risk of kidney damage over many years. With ongoing care, many people maintain stable kidney function, especially when they hit hydration goals, follow diet guidance, and use medicines that lower cystine in the urine.
Looking at the long-term picture can be helpful. Stone activity often comes in waves: some years are quiet, others busier, particularly if fluids dip or infections occur. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. A family history or certain cystinuria gene changes may increase how frequently stones form, but day-to-day habits—high fluid intake, alkalinizing the urine, and, when needed, prescriptions like thiol drugs—can significantly cut stone risk. Severe complications like chronic kidney disease are uncommon when cystinuria is actively managed, though they can occur after many untreated or complicated stones. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Cystinuria is lifelong and tends to follow a pattern of stone formation with stretches of calm between events. For some, early symptoms of cystinuria appear in childhood and the tendency to form stones continues into adulthood. Long-term effects vary widely, with some living relatively stone-free periods and others facing frequent episodes. Over time, some experience repeat procedures, while others have only occasional issues, and most maintain normal kidney function.
A lifelong tendency to form cystine stones can lead to repeated episodes at any age. Frequency ranges from rare events to many episodes per year. Stones often involve both kidneys.
Stones can block urine flow and cause swelling of the kidney. Repeated blockages may scar the kidney or ureter over time.
Most people maintain normal kidney function, but some develop chronic kidney disease after years of obstruction or infections. A small number progress to kidney failure over decades. Doctors may track these changes over years to see patterns.
Stones can increase the risk of urinary tract infections. Infections can further stress the kidneys and may trigger new stone events.
How is it to live with Cystinuria?
Living with cystinuria often means planning your day around hydration, bathrooms, and pain management, because the condition can cause repeated kidney stones that come on suddenly and intensely. Many find they carry a water bottle, track how much they drink, and follow a low–cystine diet while keeping medications and a care plan ready for flare-ups. Work, school, and travel can be disrupted by urgent pain, medical visits, or procedures, and sleep can suffer during stone episodes. Partners, family, and friends may share the load—helping with rides, childcare, or simply understanding last‑minute changes—while also learning how to spot warning signs and support prevention routines.
Treatment and drugs
Cystinuria treatment focuses on preventing kidney stones and protecting kidney function over time. For many people, treatment begins with small daily steps: drinking plenty of fluids (aiming for at least 3 liters/100 ounces a day) and adding alkaline agents like potassium citrate to make urine less acidic, which helps cystine stay dissolved. Doctors often use medicines that bind cystine, such as tiopronin or sometimes penicillamine, when fluids and urine alkalinization aren’t enough to prevent stones. Pain control, anti-nausea medicines, and procedures to remove stones—like shock wave treatment or ureteroscopy—are used if stones form or block urine flow. Because cystinuria can change over time, your doctor may adjust your dose to balance benefits and side effects and will monitor urine cystine levels, kidney function, and stone activity regularly.
Non-drug treatment
Daily habits can strongly influence how often stones form and how much they disrupt your day. Non-drug treatments often lay the foundation for living well with cystinuria. Because early symptoms of cystinuria can be subtle, building these routines early may lower stone risk over time. Your care team can personalize targets based on your age, size, other health issues, and stone history.
Aim to produce at least 3 liters (about 100 oz) of urine per day, which usually means drinking 3–4 liters (100–135 oz). Spread fluids from morning through night, including a glass before bed and another if you wake.
Keep sodium under 2,000 mg/day (about 5 g of table salt) to reduce cystine in urine. Read labels, cook at home more often, and limit salty snacks, cured meats, and takeout.
Favor moderate portions of protein (about 0.8–1 g/kg/day), with more plant proteins and fewer large servings of red meat or fish. For many with cystinuria, smaller portions across the day are easier on the kidneys.
Emphasize fruits and vegetables, legumes, and dairy alternatives that tilt urine toward a less acidic range. Citrus foods and drinks can add citrate, though diet alone may not fully alkalinize urine in cystinuria.
Your genes may have an impact on how drugs work for you
Two people can take the same cystinuria medicine and respond very differently because genes affect how fast the body activates, breaks down, or clears drugs like tiopronin, D‑penicillamine, and potassium citrate. Pharmacogenetic testing and careful dose adjustments help match therapy to your biology.
Pharmacological treatments
People with cystinuria often need medicines to prevent new stones and to manage painful flare-ups when stones move. Not everyone responds to the same medication in the same way. Even if early symptoms of cystinuria are mild, drug therapy can lower cystine levels in urine and keep urine less acidic to slow stone growth. Treatment choices depend on your kidney function, blood pressure, other health conditions, and how often stones recur.
Helps alkalinize urine toward a pH around 7–7.5 to keep cystine dissolved and lower stone risk. Can cause stomach upset and should be used carefully if you’re at risk for high potassium.
Another urine-alkalinizing option when potassium isn’t suitable. Adds sodium, so it may raise blood pressure or swelling in some people.
A cystine-binding drug that makes cystine more soluble and is used when fluids and alkalinization aren’t enough. Needs regular blood and urine monitoring for side effects like rash or protein in the urine.
Another cystine-binding option when tiopronin isn’t tolerated or available. Has a higher side-effect burden, so close monitoring of blood counts, liver, and kidney tests is important.
Genetic influences
Cystinuria often runs in families because the trait is typically inherited when two gene changes come together—one from each parent; this is known medically as autosomal recessive inheritance. In this pattern, a child needs both copies changed for the kidneys to spill extra cystine into the urine, which raises the risk of kidney stones. A “carrier” means you hold the gene change but may not show symptoms. If both parents are carriers, each pregnancy has about a 25% chance of a child with cystinuria, a 50% chance of a carrier, and a 25% chance of neither. Different families can have different gene variants, which helps explain why cystinuria can start at different ages and cause stones more or less often. Genetic testing and counseling can confirm the cause, estimate risks for relatives, and help watch for early symptoms of cystinuria in siblings.
Is Cystinuria genetic?
Genetics are central in cystinuria; it’s an inherited condition caused by changes in SLC3A1 or SLC7A9. These variants affect kidney transport, raising cystine levels and stone risk. Family history matters, and relatives may consider genetic counseling or testing.
Pharmacogenetics—how genetics influence drug effects
For Cystinuria, the same inherited changes that make the kidneys spill cystine shape the overall treatment plan—but they rarely decide which medicine you’ll take or the dose. Most care centers on drinking plenty of fluids, limiting salt, keeping urine less acidic with potassium citrate, and, if needed, using cystine‑binding medicines such as tiopronin or penicillamine; these choices are guided by your urine cystine level and how you feel on treatment more than by your exact gene result. Not every difference in response is genetic, but your care team will watch how you tolerate these medicines and adjust gradually. At this time, there aren’t widely accepted pharmacogenetic tests that tell who will do better with tiopronin versus penicillamine, or who needs a different potassium citrate dose. The genes behind cystinuria also don’t change early symptoms of cystinuria; they mainly explain why stones tend to form and who in a family may be affected. If treatment isn’t working as expected or side effects appear, your doctor will usually change the dose, switch medicines, or add other strategies rather than order a drug–gene test.
Interactions with other conditions
Kidney stones from cystinuria often show up alongside other issues, especially urinary tract infections, because stones can block urine flow and irritate the urinary tract. Doctors call it a “comorbidity” when two conditions occur together. People living with cystinuria who also have chronic diarrhea, inflammatory bowel disease, or obesity may form stones more easily, since low urine volume and more acidic urine can favor cystine crystallizing. Early symptoms of cystinuria, like burning with urination and urgent trips to the bathroom during a stone passage, can be mistaken for a simple UTI, so testing the stone type and urine chemistry matters.
Cystinuria can also intersect with high blood pressure, diabetes, or gout, which raise overall kidney stone risk and may speed kidney damage if stones keep blocking the kidneys. Repeated stones and infections can, over time, contribute to reduced kidney function, so people with cystinuria and another kidney condition need closer follow-up. During pregnancy, any stone disease—including cystinuria—can increase the chance of infections and obstruction, making coordinated care important. If you live with cystinuria and another health condition, ask whether your medications or diet for one problem could affect stone control for the other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described bouts of “gravel” or small stones passed in urine, sometimes dating back to classical texts. Families noticed patterns too: a parent and several siblings each struggling with recurrent stones from a young age, long before anyone knew why. Early physicians could see the stones but not their makeup, so treatment focused on relieving pain and preventing blockages rather than understanding the root cause.
First described in the medical literature as a distinct type of kidney stone in the 19th century, cystinuria became clearer once chemical analysis showed these stones were made of cystine, an amino acid. From these first observations, clinicians realized the condition often started in childhood or the teen years and tended to come back. Over time, descriptions became more precise: people with cystinuria frequently formed stones on both sides, and standard stone-preventing diets that helped others often fell short here.
In recent decades, knowledge has built on a long tradition of observation. Researchers linked cystinuria to a problem with how the kidneys and intestines handle certain amino acids. The transporter that normally moves cystine back into the bloodstream acts like a faulty gate; when it fails, cystine stays in the urine and can crystallize. This explained why urine tests in people with cystinuria consistently showed high cystine levels, even between stone episodes.
Advances in genetics confirmed what families had long suspected. Changes (variants) in specific genes that build the cystine transporter were identified, and inheritance patterns were mapped, explaining why cystinuria can run strongly in families and affect people of all backgrounds. This genetic insight also clarified why severity varies: some variants lead to frequent, large stones; others cause milder, sporadic issues.
As medical science evolved, so did care. Historical approaches centered on surgery when stones blocked urine flow. Today, earlier recognition, urine chemistry monitoring, hydration strategies, urine alkalinization, and medications that bind cystine can reduce stone formation and the need for procedures. Imaging has also improved, so smaller stones are found before they cause severe symptoms.
Looking back helps explain why cystinuria was once considered puzzling and stubborn to manage. The path from bedside observations to chemistry to genetics has shaped modern care, turning a condition defined by repeated crises into one where prevention and long-term planning are possible for many living with cystinuria.